Lixte Biotechnology Holdings, Inc. · NASDAQ:LIXT
Stazzone Peter received 50,000 Lixte Biotechnology Holdings, Inc. shares as an award (Form 4)
Traded Apr 15, 2026 · Filed Apr 17, 2026
On Apr 15, 2026, Stazzone Peter (Chief Financial Officer) received 50,000 Lixte Biotechnology Holdings, Inc. shares as an award, leaving 50,000 shares. Filed Apr 17, 2026 (Form 4).
- Awarded
- 50,000 shares
- Holding after
- 50,000 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 15, 2026 | Common Stock | Award | 50,000 | 50,000 | Direct |
Source
Related
- Lixte Biotechnology Holdings, Inc.
- Stazzone Peter
- Lixte Biotechnology Holdings, Inc. shareholders
- Form 4 · Stazzone Peter · Jul 2, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026
- Form 4 · Sawyer Jason David · Jul 2, 2026
- Form 4 · Pursglove Geordan Garrett · Jul 2, 2026
- Form 4 · Primus Guy Warren · Jul 2, 2026
- Form 4 · Holloway Michael Andrew · Jul 2, 2026